Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 17/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 8/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 7/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.57 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.54 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.54 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7600794 | 1.00 | CASR (0.57) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7600782 | 1.00 | CASR (0.57) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7604407 | 0.95 | CASR (0.60) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7604401 | 0.95 | CASR (0.60) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7604390 | 0.95 | CASR (0.60) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7598070 | 0.93 | CASR (0.53) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7598064 | 0.93 | CASR (0.53) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7598073 | 0.93 | CASR (0.53) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7602806 | 0.92 | CASR (0.57) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7607784 | 0.92 | CASR (0.57) | CASRCYP2D6SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6417215-B1 | USE AS CALCIUM RECEPTOR ANTAGONISTS. EXTRACELLULAR CA.SUP.2+ INHIBITS THE SECRETION OF PARATHYROID HORMONE (?PTH?) FROM PARATHYROID CELLS, | SMITHKLINE BEECHAM CORPORATION | 2002-07-09 | — | — | US | disclosed |